DENTSPLY SIRONA Inc. (XRAY) Earnings Call Analysis
NASDAQ · Healthcare · Medical Instruments & Supplies
Earnings Reports
-
XRAY Q1 2026: Gross Margin Drops 560bps as Restructuring, Distribution, and Innovation Drive Multi-Year Turnaround
May 06, 2026
-
XRAY Q4 2025: $120M Cost Restructure Funds Double-Digit R&D, Marking Capital Allocation Pivot
February 27, 2026
-
XRAY Q3 2025: U.S. Sales Drop 22% as Bold Turnaround Plan Targets 2026 Recovery
November 06, 2025
-
XRAY Q2 2025: Tariff Headwind Rises to $80M, Margin Expansion Holds Amid U.S. Weakness
August 07, 2025
-
XRAY Q1 2025: EBITDA Margin Expands 220bps as Cost Discipline Offsets Tariff Drag
July 07, 2025